XOMA Logo

XOMA Corporation (XOMA) 

NASDAQ
Market Cap
$380.4M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
773 of 776
Rank in Industry
432 of 433

Largest Insider Buys in Sector

XOMA Stock Price History Chart

XOMA Stock Performance

About XOMA Corporation

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 …

Insider Activity of XOMA Corporation

Over the last 12 months, insiders at XOMA Corporation have bought $0 and sold $0 worth of XOMA Corporation stock.

On average, over the past 5 years, insiders at XOMA Corporation have bought $8.82M and sold $1.34M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 250 shares for transaction amount of $3,473 was made by Sitko Bradley (Chief Investment Officer) on 2023‑10‑03.

List of Insider Buy and Sell Transactions, XOMA Corporation

2023-10-03PurchaseChief Investment Officer
250
0.0022%
$13.89$3,473+74.42%
2023-10-02PurchaseChief Investment Officer
1,500
0.0133%
$14.25$21,375+71.54%
2023-10-02PurchaseExec Chairman and Interim CEO
1,000
0.0086%
$13.83$13,830+71.54%
2023-09-26PurchaseExec Chairman and Interim CEO
2,499
0.0221%
$14.43$36,061+67.84%
2023-09-25PurchaseExec Chairman and Interim CEO
1
<0.0001%
$14.65$15+62.26%
2023-05-31PurchaseChief Investment Officer
1,500
0.0132%
$17.13$25,700+6.76%
2023-05-24PurchaseInterim CEO
1,032
0.012%
$23.79$24,551+0.22%
2023-05-23PurchaseChief Investment Officer
850
0.0076%
$19.00$16,150-4.09%
2023-05-23PurchaseInterim CEO
968
0.0107%
$23.46$22,706-4.09%
2023-05-19PurchaseChief Investment Officer
1,000
0.0088%
$19.50$19,500-8.70%
2023-05-16PurchaseChief Investment Officer
500
0.0049%
$23.20$11,602-13.17%
2023-05-15PurchaseChief Investment Officer
1,500
0.0153%
$23.40$35,100-11.27%
2023-05-12PurchaseChief Investment Officer
2,000
0.0173%
$18.99$37,985-7.31%
2023-01-06Purchasedirector
3,249
0.0282%
$21.98$71,419-19.69%
2023-01-06Purchasedirector
1,573
0.0137%
$21.98$34,577-19.69%
2023-01-05Purchasedirector
19,000
0.1396%
$18.39$349,319-18.64%
2023-01-05Purchasedirector
15,670
0.1152%
$18.39$288,096-18.64%
2022-07-15SaleCEO
20,883
0.1824%
$29.55$617,095-36.18%
2022-07-15SaleSVP, Finance & CFO
2,000
0.0187%
$31.66$63,321-36.18%
2022-03-21SaleCEO
2,339
0.021%
$30.02$70,209-33.94%

Insider Historical Profitability

21.93%
BAKER JULIANdirector
17888512
152.8345%
$32.5010
BVF PARTNERS L P/ILdirector
1618637
13.8292%
$32.50480+31.12%
PERRY MATTHEW DSee Explanation of Responses
200000
1.7087%
$32.5010<0.0001%
DAVIS PETER BVP, Finance & CFO
94960
0.8113%
$32.5010<0.0001%
BAKER BROS. ADVISORS LPother
90538
0.7735%
$32.50117+28.45%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Bvf Inc Il$87.39M31.223.63M0%+$00.64
Fidelity Investments$27.91M9.971.16M+0.48%+$133,886.35<0.01
BlackRock$11.56M4.13480,508-1.63%-$191,846.86<0.0001
The Vanguard Group$9.75M3.48405,533-3.78%-$383,381.02<0.0001
Stonepine Capital Management Llc$6.1M2.18253,770+1.51%+$90,668.510.37
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.